Thrombophilic Status May Predict Prognosis in Patients With Metastatic BRAFV600-mutated Melanoma Who Are Receiving BRAF Inhibitors
Journal of the American Academy of Dermatology - United States
doi 10.1016/j.jaad.2015.11.006
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 2016
Authors
Publisher
Elsevier BV